Formulation and Delivery
Sachin Mittal, PhD (he/him/his)
Executive Director, Pharmaceutical Sciences & Clinical Supplies
Merck & Co., Inc., New Jersey
Andre Hermans, PhD (he/him/his)
Executive Director
Merck & Co., Inc.
Rahway, New Jersey
There has been a significant growth in novel modalities in the industry portfolio driven by better access to target, improved therapeutic index/ patient outcomes, and potentially patient access (COGMs, administration). The presentation will highlight the growth of a few of these novel modalities and their development challenges and opportunities that are driving scientific and operational investments in development & manufacturing.